Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 325.54B | 279.16B | 245.88B | 214.39B | 189.72B |
Gross Profit | 190.43B | 163.61B | 202.97B | 113.84B | 103.08B |
EBITDA | 96.67B | 88.42B | 74.43B | 47.74B | 45.71B |
Net Income | 56.54B | 55.68B | 45.07B | 23.57B | 17.24B |
Balance Sheet | |||||
Total Assets | 492.99B | 387.52B | 322.85B | 296.65B | 265.49B |
Cash, Cash Equivalents and Short-Term Investments | 57.91B | 81.47B | 66.75B | 44.37B | 34.57B |
Total Debt | 46.77B | 20.02B | 13.47B | 33.84B | 30.31B |
Total Liabilities | 155.82B | 106.97B | 89.99B | 106.13B | 90.51B |
Stockholders Equity | 333.39B | 280.55B | 232.86B | 190.53B | 174.98B |
Cash Flow | |||||
Free Cash Flow | 12.03B | 18.00B | 40.01B | 9.06B | 23.14B |
Operating Cash Flow | 46.43B | 45.43B | 58.87B | 28.11B | 35.70B |
Investing Cash Flow | -58.08B | -40.28B | -41.37B | -26.39B | -22.66B |
Financing Cash Flow | 18.91B | -3.76B | -26.86B | -2.42B | -298.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $13.23B | 45.32 | 12.43% | ― | 21.73% | -19.24% | |
73 Outperform | $5.07B | 20.80 | 24.11% | ― | 12.53% | -45.33% | |
71 Outperform | $12.20B | 18.26 | 18.36% | 0.03% | 13.03% | -0.49% | |
65 Neutral | ¥355.44B | 11.10 | -2.99% | 2.49% | 11.76% | -10.16% | |
55 Neutral | $19.15B | ― | -18.98% | ― | 3.38% | -175.90% | |
54 Neutral | $11.00B | ― | -21.25% | 5.12% | -6.88% | -6809.78% |